US Stock MarketDetailed Quotes
KMX CarMax
- 69.220
- -1.050-1.49%
Close Apr 25 16:00 ET
- 70.000
- +0.780+1.13%
Post 19:25 ET
10.89BMarket Cap22.92P/E (TTM)
69.560High67.650Low2.81MVolume69.040Open70.270Pre Close193.40MTurnover1.79%Turnover Ratio22.92P/E (Static)157.39MShares88.22052wk High1.79P/B10.84BFloat Cap59.66052wk Low--Dividend TTM156.60MShs Float155.980Historical High--Div YieldTTM2.72%Amplitude0.656Historical Low68.832Avg Price1Lot Size
CarMax Stock Forum
Sign in to post a comment
$CapLand Ascendas REIT(A17U.SG$$HongkongLand USD(H78.SG$$Mapletree Log Tr(M44U.SG$$Mapletree PanAsia Com Tr(N2IU.SG$
CNBC’s Jim Cramer admitted it’s been hard to “parse this economy,” but on Tuesday he pointed to signs that it is slowing down, looking at several recent weak earnings reports and new U.S. manufacturing and services data.
Cramer referred to these factors as “brown shoots” that are disrupting U.S. economic growth.
“When you combine the anecdotal evidence with the em...
CNBC’s Jim Cramer admitted it’s been hard to “parse this economy,” but on Tuesday he pointed to signs that it is slowing down, looking at several recent weak earnings reports and new U.S. manufacturing and services data.
Cramer referred to these factors as “brown shoots” that are disrupting U.S. economic growth.
“When you combine the anecdotal evidence with the em...
1
1
ColumnsToday's Morning Movers and Top Ratings: NKE, AMZN, KMX, V and More
Morning Movers
Gapping up
$Nike(NKE.US$ stock increased by 1.4% after the sportswear company revealed its Olympic kits, aiming to leverage the appeal of top athletes to attract more consumers.
$Alpine Immune(ALPN.US$ stock surged over 36% after Vertex Pharmaceuticals announced its plan to acquire the biotech company for about $4.9 billion in cash, which would give Vertex access to a treatment for an autoimmune kidney disease.
$Rent the Runway(RENT.US$ stock ju...
Gapping up
$Nike(NKE.US$ stock increased by 1.4% after the sportswear company revealed its Olympic kits, aiming to leverage the appeal of top athletes to attract more consumers.
$Alpine Immune(ALPN.US$ stock surged over 36% after Vertex Pharmaceuticals announced its plan to acquire the biotech company for about $4.9 billion in cash, which would give Vertex access to a treatment for an autoimmune kidney disease.
$Rent the Runway(RENT.US$ stock ju...
28
Analysts predict CarMax's earnings report could boost stock gains, turning a modest sales rise into a larger earnings increase through cost control. They also foresee potential for mid-single-digit annual revenue growth over the next three years if online sales persist. Needham analyst Chris Pierce upgraded the stock to Buy from Hold on March 20, with a price target of $99.
1
Despite some analysts' optimism, Wall Street remains skeptical about CarMax, with less than half recommending a Buy. Carvana's average price target suggests a 28% drop. Concerns linger about Amazon's entry into auto sales and the volatile used car market.
2
The declining ROCE and sales for CarMax, along with the increased capital employment, are concerning. Despite the stock's rise in the last five years, the current trends do not inspire confidence in the company's future performance.
Oppenheimer sees Vroom's departure as a chance for CarMax to gain market share and face one less national rival. The firm also highlights potential demand due to aging vehicles in the U.S. and consumers returning to the market as affordability improves.
1
Despite CarMax's recent sell-off, sustained long-term growth could make it a potential investment. However, investors should note a warning sign spotted with the company.
Camping World outperformed analysts' earnings estimates, while Lithia Motors and CarMax had mixed results. America's Car-Mart underperformed with increased credit losses.
$CarMax(KMX.US$ needs to break 77.7 this week to go higher
$CarMax(KMX.US$ is this a good stock .hmmm
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Deep SeaOP : Bad news for the economy is positive for stocks.